Long-term Prospective Cohort Study of Patients Undergoing Pancreatectomy for Intraductal Papillary Mucinous Neoplasm of the Pancreas
- 1 August 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 260 (2) , 356-363
Abstract
Objective: To evaluate long-term follow-up results after surgical treatment of intraductal papillary mucinous neoplasm (IPMN) to optimize postoperative surveillance strategies. Background: Little is known about the postoperative natural history of IPMN, especially about long-term follow-up results in patients with benign or noninvasive IPMN. Methods: Long-term follow-up was undertaken in a prospective cohort of 403 consecutive patients who underwent surgical treatment of IPMN at Seoul National University Hospital. Of these, 37 patients with ductal adenocarcinoma arising in IPMN were excluded from the analysis. Results: Of the 366 patients, 82 had low-grade dysplasia, 171 had intermediate-grade dysplasia, 45 had high-grade dysplasia, and 68 had IPMN with associated invasive carcinoma. During a median follow-up of 44.4 months, the overall recurrence rate was 10.7%. Pathologic grade of dysplasia was associated with recurrence rate (P < 0.001). IPMNs involving main duct had higher rate of recurrence (P = 0.021). Of the 298 patients with benign or noninvasive IPMN, 16 (5.4%) had recurrences including distant metastasis. Multivariate analysis revealed that the degree of dysplasia was the most important predictor of recurrence (P < 0.001). The overall 5-year disease-free survival rate was 78.9% and was significantly lower in patients with high-grade dysplasia than in those with low- or intermediate-grade dysplasia (P = 0.045). Conclusions: Pancreatic IPMNs recur in 10.7% of patients. Recurrence is correlated with the degree of dysplasia, and 5.4% of patients with benign or noninvasive IPMN have recurrences including distant metastasis. Thorough postoperative surveillance is needed not only for patients with invasive IPMN but also for those with benign or noninvasive IPMN, especially for patients with high-grade dysplasia.Keywords
This publication has 20 references indexed in Scilit:
- Fate of the Pancreatic Remnant After Resection for an Intraductal Papillary Mucinous Neoplasm2012
- Recurrences After Surgical Resection of Intraductal Papillary Mucinous Neoplasm of the PancreasPancreas, 2012
- Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasmHPB, 2011
- Cyst Growth Rate Predicts Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous NeoplasmsClinical Gastroenterology and Hepatology, 2011
- Risk Factors Associated With the Postoperative Recurrence of Intraductal Papillary Mucinous Neoplasms of the PancreasPancreas, 2011
- Clinicopathologic analysis of surgically proven intraductal papillary mucinous neoplasms of the pancreas in SNUH: a 15-year experience at a single academic institutionLangenbeck's Archives of Surgery, 2010
- Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single centerJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the PancreasPancreatology, 2006
- Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreasGastroenterology, 2002
- Outcome After Surgical Resection of Intraductal Papillary and Mucinous Tumors of The PancreasAmerican Journal of Gastroenterology, 2000